VB Spine LLC announced that it has completed the acquisition of Stryker Corporation’s spine implant manufacturing facility in Cestas, France, on January 6, 2026. The transaction expands VB Spine’s global manufacturing footprint and positions the company to serve a broader customer base across Europe.
The Cestas plant, known for its state‑of‑the‑art operations and highly skilled workforce, will now operate under VB Spine ownership. The acquisition is part of VB Spine’s strategy to consolidate its manufacturing capabilities and accelerate the rollout of its medical‑education and training programs throughout the continent. John Viscogliosi, co‑CEO of VB Spine, said the team in Cestas “brings deep expertise and a strong track record in manufacturing excellence. We’re thrilled to welcome them to VB Spine and excited for the role they will play in our future. Cestas will anchor our worldwide manufacturing capabilities and give us a strong platform to deliver training and best practices to surgeons.”
Stryker’s divestiture of the Cestas facility aligns with its broader portfolio realignment, which focuses on higher‑growth, higher‑margin areas such as robotics and vascular medicine. The sale follows Stryker’s decision to spin off its U.S. spine business earlier in 2025, a move that has freed capital for investment in emerging technologies. The transaction also preserves a strategic partnership: VB Spine will retain exclusive access to Stryker’s Mako Spine robotics platform and Copilot guidance software, ensuring continuity of technology integration for its implant line.
The acquisition strengthens VB Spine’s competitive position in a market that is increasingly consolidating around advanced manufacturing and digital solutions. By adding the Cestas facility, VB Spine gains a high‑capacity production hub that can support rapid scaling of its implant portfolio and support the company’s goal of becoming the largest privately held spine company. The move also positions VB Spine to better serve European surgeons with localized manufacturing, reducing lead times and enhancing supply chain resilience.
The deal underscores Stryker’s strategic shift toward more profitable, technology‑driven segments. While the financial terms of the transaction were not disclosed, the acquisition reflects a broader industry trend of companies divesting legacy businesses to focus on high‑growth opportunities. For VB Spine, the addition of Cestas is a key milestone in its expansion strategy and a signal of its intent to compete aggressively in the evolving spine market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.